Smokeless tobacco: An emerging addiction

Medical Clinics of North America

Volumn 88, Issue 6, 2004, Pages 1593-1605

  Ebbert, Jon O ^a,b   Carr, Alan B ^a,b   Dale, Lowell C ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ADDICTION; CIGARETTE SMOKING; DRUG WITHDRAWAL; HEALTH; HEALTH HAZARD; HUMAN; NICOTINE REPLACEMENT THERAPY; OROPHARYNX; PERIODONTIUM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOOTH; UNITED STATES;

HUMANS; MOUTH DISEASES; TOBACCO USE CESSATION; TOBACCO USE DISORDER; TOBACCO, SMOKELESS; UNITED STATES;

EID: 4644242040     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.06.003     Document Type: Review

References (69)

1. J. Rogozinski Smokeless tobacco in the western world 1990 Praeger Publishers New York
2. National Institutes of Health The health consequences of using smokeless tobacco: a report of the Advisory Committee to the Surgeon General 1986 US Department of Health and Human Services Bethesda Publication #NIH 86-2874
3. J.A. Critchley, and B. Unal Health effects associated with smokeless tobacco: a systematic review Thorax 58 2003 435 443
4. Office of Applied Studies. Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse, 1999. US Department of Health and Human Services. Available at: http://www.oas.samhsa.gov/nhsda.htm. Accessed July 8, 2004.
5. E.D. Glover, and P.N. Glover The smokeless tobacco problem: risk groups in North America National Cancer Institute. Smokeless tobacco or health: an international perspective 1992 US Department of Health and Human Services, Public Health Service Washington 3 10 Publication #NIH 93-3461
6. Centers for Disease Control and Prevention Determination of nicotine, pH, and moisture content of six US commercial moist snuff products - Florida, January-February 1999 MMWR Morb Mortal Wkly Rep 48 1999 398 401
7. S.L. Tomar, and J.E. Henningfield Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco Tob Control 6 1997 219 225
8. J.E. Henningfield, A. Radzius, and E.J. Cone Estimation of available nicotine content of six smokeless tobacco products Tob Control 4 1995 57 61
9. G.N. Connolly The marketing of nicotine addiction by one oral snuff manufacturer Tob Control 4 1995 73 79
10. N.L. Benowitz Pharmacology of smokeless tobacco use: nicotine addiction and nicotine-related health consequences National Cancer Institute. Smokeless tobacco or health: an international perspective 1992 US Department of Health and Human Services, Public Health Service Washington 219 227 Publication #NIH 93-3461
11. Food and Drug Administration Nicotine in cigarettes and smokeless tobacco is a drug and these products are nicotine delivery devices under the Federal Food, Drug, and Cosmetic Act: jurisdictional determination Federal Registrar 61 1996 44619 44627
12. R.V. Fant, J.E. Henningfield, R.A. Nelson, and W.B. Pickworth Pharmacokinetics and pharmacodynamics of moist snuff in humans Tob Control 8 1999 387 392
13. S.L. Tomar, G.A. Giovino, and M.P. Erikson Smokeless tobacco brand preference and brand switching among US adolescents and young adults Tob Control 4 1995 67 72
14. N.L. Benowitz, H. Porchet, L. Sheiner, and P.D. Jacob Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum Clin Pharmacol Ther 44 1988 23 28
15. D.K. Hatsukami, and H.H. Severson Oral spit tobacco: addiction, prevention and treatment Nicotine Tob Res 1 1999 21 44
16. National Cancer Institute Smokeless tobacco or health: an international perspective 1992 US Department of Health and Human Services, Public Health Service Washington Publication #NIH 93-3461
17. Office of Evaluations and Inspections Spit tobacco and youth 1992 US Department of Health and Human Services, Office of the Inspector General Washington Publication #DHHS (OE1-06) 92-00500
18. Office of Applied Studies. Substance Abuse and Mental Health Services Administration. Summary of findings from the 1999 National Household Survey on Drug Abuse. National Household Survey on Drug Abuse Series: H-12, Publication #DHHS SMA 00-3466. Available at: http://www.DrugAbuseStatistics.samhsa.gov/. Accessed December 30, 2003.
19. Federal Trade Commission. Federal Trade Commission smokeless tobacco report for the years 2000 and 2001. Available at: http://www1.ftc.gov/os/2003/ 08/2k2k1smokeless.pdf. Accessed December 30, 2003.
20. Office of Applied Studies of the Substance Abuse. Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings. Publication #DHHS SMA 03-3836, NHSDA Series H-22. Available at: http://www.oas.samhsa.gov/nhsda.htm. Accessed December 30, 2003.
21. National Cancer Institute. Cigars: health effects and trends smoking and tobacco control monograph No. 9. Available at: http://cancercontrol.cancer.gov/ tcrb/monographs/9/index.html. Accessed December 30, 2003.
22. Centers for Disease Control Use of smokeless tobacco among adults - United States, 1991 MMWR Morb Mortal Wkly Rep 42 1991 263 266
23. M.J. Jarvis Dependence on smokeless tobacco National Cancer Institute. Smokeless tobacco or health: an international perspective 1992 US Department of Health and Human Services, Public Health Service Washington 239 244 Publication #NIH 93-3461
24. D.K. Hatsukami, S.W. Gust, and R.M. Keenan Physiologic and subjective changes from smokeless tobacco withdrawal Clin Pharmacol Ther 41 1987 103 107
25. D.E. McChargue, and F.L. Collins Jr. Differentiating withdrawal patterns between smokers and smokeless tobacco users Exp Clin Psychopharmacol 6 1998 205 208
26. R.M. Keenan, D.K. Hatsukami, and D.J. Anton The effects of short-term smokeless tobacco deprivation on performance Psychopharmacology (Berl) 98 1989 126 130
27. R. Boyle, J. Jensen, and D. Hatsukami Measuring dependence in smokeless tobacco users Addict Behav 20 1995 443 450
28. N.L. Benowitz, P.D. Jacob, and L. Yu Daily use of smokeless tobacco: systemic effects Ann Intern Med 111 1989 112 116
29. National Toxicology Program. Tenth report on carcinogens. Available at: http://ehp.niehs.nih.gov/roc/toc10.html. Accessed December 30, 2003.
30. International Agency for Research on Cancer IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Tobacco habits other than smoking; betel quid and areca nut chewing; and some related nitrosamines 1985 International Agency for Research on Cancer Lyon
31. G. Bolinder, L. Alfredsson, A. Englund, and U. de Faire Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers Am J Public Health 84 1994 399 404
32. G.M. Bolinder, B.O. Ahlborg, and J.H. Lindell Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey J Intern Med 232 1992 327 334
33. S.L. Tomar, and D.M. Winn Chewing tobacco use and dental caries among US men J Am Dent Assoc 130 1999 1601 1610
34. P.M. Walsh, and J.B. Epstein The oral effects of smokeless tobacco J Can Dent Assoc 66 2000 22 25
35. W.H. Bowles, M.R. Wilkinson, M.J. Wagner, and R.D. Woody Abrasive particles in tobacco products: a possible factor in dental attrition J Am Dent Assoc 126 1995 327 331 quiz 348
36. A. Milosevic, and M.S. Lo Tooth wear in three ethnic groups in Sabah (northern Borneo) Int Dent J 46 1996 572 578
37. S. Offenbacher, and D.R. Weathers Effects of smokeless tobacco on the periodontal, mucosal and caries status of adolescent males J Oral Pathol 14 1985 169 181
38. V.L. Ernster, D.G. Grady, J.C. Greene, M. Walsh, P. Robertson, and T.E. Daniels Smokeless tobacco use and health effects among baseball players JAMA 264 1990 218 224
39. G.K. Johnson, and C.C. Organ Prostaglandin E2 and interleukin-1 concentrations in nicotine-exposed oral keratinocyte cultures J Periodontal Res 32 1997 447 454
40. G.K. Johnson, T.K. Poore, J.B. Payne, and C.C. Organ Effect of smokeless tobacco extract on human gingival keratinocyte levels of prostaglandin E2 and interleukin-1 J Periodontol 67 1996 116 124
41. G.H. Lei, K.H. Li, and J.N. Zhou Effect of nicotine on the secretion of TNF of human peripheral blood mononuclear cells in vitro Hunan Yi Ke Da Xue Xue Bao 27 2002 285 287
42. S.J. Little, V.J. Stevens, P.A. LaChance, H.H. Severson, M.H. Bartley, and E. Lichtenstein Smokeless tobacco habits and oral mucosal lesions in dental patients J Public Health Dent 52 1992 269 276
43. J.M. Hirsch, G. Heyden, and H. Thilander A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity J Oral Pathol 11 1982 387 398
44. S. Silverman Jr., M. Gorsky, and F. Lozada Oral leukoplakia and malignant transformation: a follow-up study of 257 patients Cancer 53 1984 563 568
45. S. Silverman, K. Bhargava, L.W. Smith, and A.M. Malaowalla Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India Cancer 38 1976 1790 1795
46. G. Taybos Oral changes associated with tobacco use Am J Med Sci 326 2003 179 182
47. D.M. Winn, W.J. Blot, C.M. Shy, L.W. Pickle, A. Toledo, and J.F. Fraumeni Jr. Snuff dipping and oral cancer among women in the southern United States N Engl J Med 304 1981 745 749
48. H.G. Stockwell, and G.H. Lyman Impact of smoking and smokeless tobacco on the risk of cancer of the head and neck Head Neck Surg 9 1986 104 110
49. R.R. Williams, and J.W. Horm Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey J Natl Cancer Inst 58 1977 525 547
50. J.O. Ebbert, L.C. Rowland, V.M. Montori, K.S. Vickers, P.J. Erwin, and L.C. Dale Treatments for spit tobacco use: a quantitative systematic review Addiction 98 2003 569 583
51. H.H. Severson, J.A. Andrews, E. Lichtenstein, J.S. Gordon, and M.F. Barckley Using the hygiene visit to deliver a tobacco cessation program: results of a randomized clinical trial J Am Dent Assoc 129 1998 993 999
52. M.M. Walsh, J.F. Hilton, C.M. Masouredis, L. Gee, M.A. Chesney, and V.L. Ernster Smokeless tobacco cessation intervention for college athletes: results after 1 year Am J Public Health 89 1999 228 234
53. B.J. Chakravorty A product substitution approach to adolescent smokeless tobacco cessation Diss Abstr Int 53 1992 2808 2809
54. S. Cummings An evaluation of a behavioral change intervention for smokeless tobacco use Diss Abstr Int 56 1995 6692
55. E.D. Glover, M.Q. Wang, and P.N. Glover Development of a high school smokeless tobacco cessation manual Health Values 18 1994 28 33
56. N.J. Williams, K.L. Arheart, and R. Klesges A smokeless tobacco cessation program for postsecondary students Health Values 19 1995 33 42
57. H.H. Severson, J.A. Andrews, E. Lichtenstein, J.S. Gordon, M. Barckley, and L. Akers A self-help cessation program for smokeless tobacco users: comparison of two interventions Nicotine Tob Res 2 2000 363 370
58. H.H. Severson, L. Akers, J.A. Andrews, E. Lichtenstein, and A. Jerome Evaluating two self-help interventions for smokeless tobacco cessation Addict Behav 25 2000 465 470
59. R.G. Boyle Smokeless tobacco cessation with nicotine replacement: a randomized clinical trial Diss Abstr Int 54 1992 825
60. D. Hatsukami, J. Jensen, S. Allen, M. Grillo, and R. Bliss Effects of behavioral and pharmacological treatment on smokeless tobacco users J Consult Clin Psychol 64 1996 153 161
61. B. Howard-Pitney, J. Killen, and S. Fortmann Quitting chew: results from a randomized trail using nicotine patches Exp Clin Psychopharmacol 7 1999 362 371
62. D.K. Hatsukami, M. Grillo, R. Boyle, S. Allen, J. Jensen, and R. Bliss Treatment of spit tobacco users with transdermal nicotine system and mint snuff J Consult Clin Psychol 68 2000 241 249
63. E. Glover, P. Glover, C. Sullivan, C. Cerullo, and G. Hobbs A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation Am J Health Behav 26 2002 386 393
64. L.C. Dale, J.O. Ebbert, D.R. Schroeder, I.T. Croghan, D.F. Rasmussen, and J.A. Trautman Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study Nicotine Tob Res 4 2002 267 274
65. H.H. Severson What have we learned from 20 years of research on smokeless tobacco cessation? Am J Med Sci 326 2003 206 211
66. J.A. Andrews, H.H. Severson, E. Lichtenstein, J.S. Gordon, and M.F. Barckley Evaluation of a dental office tobacco cessation program: effects on smokeless tobacco use Ann Behav Med 21 1999 48 53
67. M.C. Fiore, W.C. Bailey, and S.J. Cohen Treating tobacco use and dependence 2000 US Department of Health and Human Services, Public Health Service Rockville (MD)
68. L.C. Dale, R.D. Hurt, K.P. Offord, G.M. Lawson, I.T. Croghan, and D.R. Schroeder High-dose nicotine patch therapy: percentage of replacement and smoking cessation JAMA 274 1995 1353 1358
69. National Institute of Dental and Craniofacial Research. National Institutes of Health. Detecting oral cancer: a guide for health care professionals. National Oral Health Information Clearinghouse (NOHIC). Available at: http://www.nohic.nidcr.nih.gov/pubs/detect/index.html. Accessed December 30, 2003.